Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of a gene expression driven progression pathway in myxoid liposarcoma.
De Cecco L, Negri T, Brich S, Mauro V, Bozzi F, Dagrada G, Disciglio V, Sanfilippo R, Gronchi A, D'Incalci M, Casali PG, Canevari S, Pierotti MA, Pilotti S. De Cecco L, et al. Among authors: casali pg. Oncotarget. 2014 Aug 15;5(15):5965-77. doi: 10.18632/oncotarget.2023. Oncotarget. 2014. PMID: 25115389 Free PMC article.
Trabectedin therapy for sarcomas.
Casali PG, Sanfilippo R, D'Incalci M. Casali PG, et al. Curr Opin Oncol. 2010 Jul;22(4):342-6. doi: 10.1097/CCO.0b013e32833aaac1. Curr Opin Oncol. 2010. PMID: 20489618 Review.
Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma.
Negri T, Brich S, Conca E, Bozzi F, Orsenigo M, Stacchiotti S, Alberghini M, Mauro V, Gronchi A, Dusio GF, Pelosi G, Picci P, Casali PG, Pierotti MA, Pilotti S. Negri T, et al. Among authors: casali pg. Genes Chromosomes Cancer. 2012 Feb;51(2):111-26. doi: 10.1002/gcc.20933. Epub 2011 Nov 1. Genes Chromosomes Cancer. 2012. PMID: 22045652
The intriguing patterns of tumor response to trabectedin.
Sanfilippo R, Casali PG. Sanfilippo R, et al. Among authors: casali pg. Expert Rev Anticancer Ther. 2013 Jun;13(6 Suppl 1):21-4. doi: 10.1586/era.13.51. Expert Rev Anticancer Ther. 2013. PMID: 23638727
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma.
Mannarino L, Craparotta I, Ballabio S, Frapolli R, Meroni M, Bello E, Panini N, Callari M, Sanfilippo R, Casali PG, Barisella M, Fabbroni C, Marchini S, D'Incalci M. Mannarino L, et al. Among authors: casali pg. Genomics. 2021 Sep;113(5):3439-3448. doi: 10.1016/j.ygeno.2021.07.028. Epub 2021 Jul 30. Genomics. 2021. PMID: 34339817 Free article.
Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas.
Tamborini E, Miselli F, Negri T, Lagonigro MS, Staurengo S, Dagrada GP, Stacchiotti S, Pastore E, Gronchi A, Perrone F, Carbone A, Pierotti MA, Casali PG, Pilotti S. Tamborini E, et al. Among authors: casali pg. Clin Cancer Res. 2006 Dec 1;12(23):6920-8. doi: 10.1158/1078-0432.CCR-06-1584. Clin Cancer Res. 2006. PMID: 17145809
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study.
Grosso F, Jones RL, Demetri GD, Judson IR, Blay JY, Le Cesne A, Sanfilippo R, Casieri P, Collini P, Dileo P, Spreafico C, Stacchiotti S, Tamborini E, Tercero JC, Jimeno J, D'Incalci M, Gronchi A, Fletcher JA, Pilotti S, Casali PG. Grosso F, et al. Among authors: casali pg. Lancet Oncol. 2007 Jul;8(7):595-602. doi: 10.1016/S1470-2045(07)70175-4. Lancet Oncol. 2007. PMID: 17586092
Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.
Germano G, Frapolli R, Simone M, Tavecchio M, Erba E, Pesce S, Pasqualini F, Grosso F, Sanfilippo R, Casali PG, Gronchi A, Virdis E, Tarantino E, Pilotti S, Greco A, Nebuloni M, Galmarini CM, Tercero JC, Mantovani A, D'Incalci M, Allavena P. Germano G, et al. Among authors: casali pg. Cancer Res. 2010 Mar 15;70(6):2235-44. doi: 10.1158/0008-5472.CAN-09-2335. Epub 2010 Mar 9. Cancer Res. 2010. PMID: 20215499
428 results